Avail. Clinical Research, LLC
DeLand, Florida 32720
0 studies enrolling now · 117 studies all time
What they study most
Acute Migraine, Alzheimer Disease, Analgesia, Anthrax, Arthritis, Arthritis, Rheumatoid, Asthma, Attention Deficit Hyperactivity Disorder (ADHD), Cancer, Chronic Hepatitis B, Chronic Hepatitis C Virus, Chronic Low Back Pain
Studies at this site
- A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
- A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia — Completed
- Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived) — Completed
- Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study — Completed
- A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder — Completed
- A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
- A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
- A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause — Completed
- A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause — Completed
- Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
- Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy — Completed
- PF-04634817 Renal Impairment Study — Completed
- A Study of Mirikizumab in Participants With Plaque Psoriasis — Completed
- A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. — Completed
- Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
- Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age — Completed
- Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure — Completed
- Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension — Completed
- A Phase 3 Efficacy and Safety Study of Intra-articular CNTX-4975-05 (Capsaicin) vs Placebo in Subjects With OA Knee Pain — Completed
- Evaluation of Galcanezumab in the Prevention of Chronic Migraine — Completed
- A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults — Completed
- Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants — Stopped early
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis — Completed
- A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
- A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis — Completed
- A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
- Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD) — Completed
- Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) — Completed
- Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration — Completed
- A Pilot Study of KPL-914 in Recurrent Pericarditis — Completed
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
- Tanezumab In Osteoarthritis Of The Knee (2) — Completed
- Extension Study Of Tanezumab In Osteoarthritis — Stopped early
- Dextromethorphan Pediatric Acute Cough Study — Stopped early
- Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
- A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years — Completed
- Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder — Completed
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
- Tanezumab in Osteoarthritis Of The Hip — Completed
- MLE4901 vs. Placebo for the Treatment of PCOS — Stopped early
- Effect of Hepatic Impairment on LDK378 Pharmacokinetics — Completed
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection — Completed
- A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — Completed
- An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
- A Study of LY2623091 in Participants With High Blood Pressure — Completed
- A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects — Completed
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
- Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis — Completed
- Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
- Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed